In-kind

LAB150

The goal of LAB150 is to develop new treatments and cures for serious and debilitating diseases. We are creating a new blueprint for translating academic research into market-ready products.

  • 4.5/5.0
  • Toronto Innovation Acceleration Partners (TIAP)
  • All levels
  • Last updated 3 years ago
  • English
Description
The goal of LAB150 is to develop new treatments and cures for serious and debilitating diseases. We are creating a new blueprint for translating academic research into market-ready products.

LAB150 helps innovators access a wide range of drug discovery and development capabilities, including: Target Identification and Validation; Screening and Hit Identification; Testing Novel Therapeutics in In-Vivo Models; Drug Metabolism and Pharmacokinetics; Medicinal Chemistry; Proteomics and Metabolomics.